Y. I. Wolf, Origins and Evolution of the Global RNA Virome, vol.9, pp.2329-02318, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-01977324

M. E. Woolhouse and L. Brierley, Epidemiological characteristics of human-infective RNA viruses, Scientific Data, vol.5, p.180017, 2018.

D. H. Chung, Discovery of a Broad-Spectrum Antiviral Compound That Inhibits Pyrimidine Biosynthesis and Establishes a Type 1 Interferon-Independent Antiviral State, Antimicrob Agents Chemother, vol.60, pp.4552-4562, 2016.

P. C. Delekta, Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo, J Virol, vol.88, pp.11199-11214, 2014.

C. Jeronimo and D. Archambault, Importance of M-protein C terminus as substrate antigen for serodetection of equine arteritis virus infection, Clinical and diagnostic laboratory immunology, vol.9, pp.698-703, 2002.

P. J. Timoney and W. H. Mccollum, Equine viral arteritis. The Veterinary clinics of North America, Equine practice, vol.9, pp.295-309, 1993.

U. B. Balasuriya, M. Carossino, and P. J. Timoney, Equine viral arteritis: A respiratory and reproductive disease of significant economic importance to the equine industry. Equine Veterinary Education, vol.30, pp.497-512, 2018.

J. Zhang, D. A. Stein, P. J. Timoney, and U. B. Balasuriya, Curing of HeLa cells persistently infected with equine arteritis virus by a peptide-conjugated morpholino oligomer, Virus research, vol.150, pp.138-142, 2010.

S. Lazic, Serological evidence of equine arteritis virus infection and phylogenetic analysis of viral isolates in semen of stallions from Serbia, BMC Vet Res, vol.13, p.316, 2017.

J. Choi, Synergistic effect of ribavirin and vaccine for protection during early infection stage of foot-and-mouth disease, Journal of veterinary science, vol.19, pp.788-797, 2018.

S. Chevaliez, Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues, Journal of viral hepatitis, vol.26, pp.278-286, 2019.

M. Gotte, Resistance to nucleotide analogue inhibitors of hepatitis C virus NS5B: mechanisms and clinical relevance. Current opinion in virology, vol.8, pp.104-108, 2014.

D. Topalis, Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1, Oncotarget, vol.7, pp.10386-10401, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01427117

Y. Kim and C. Lee, Ribavirin efficiently suppresses porcine nidovirus replication, Virus Research, vol.171, pp.44-53, 2013.

S. Larrat, Ribavirin quantification in combination treatment of chronic hepatitis C, Antimicrobial agents and chemotherapy, vol.47, pp.124-129, 2003.

G. Lanave, Ribavirin and boceprevir are able to reduce Canine distemper virus growth in vitro, Journal of Virological Methods, vol.248, pp.207-211, 2017.

N. A. Ilyushina, Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice, Antimicrobial Agents and Chemotherapy, vol.52, p.3889, 2008.

R. C. Weiss, N. R. Cox, and M. K. Boudreaux, Toxicologic effects of ribavirin in cats, Journal of Veterinary Pharmacology and Therapeutics, vol.16, pp.301-316, 1993.

B. M. Wohl, A. A. Smith, M. B. Kryger, and A. N. Zelikin, Narrow Therapeutic Window of Ribavirin as an Inhibitor of Nitric Oxide Synthesis is Broadened by Macromolecular Prodrugs, Biomacromolecules, vol.14, pp.3916-3926, 2013.

M. L. Moreli, A. C. Marques-silva, V. A. Pimentel, and C. Da, Effectiveness of the ribavirin in treatment of hantavirus infections in the Americas and Eurasia: a meta-analysis. Virusdisease, vol.25, pp.385-389, 2014.

N. I. Nii-trebi, Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges, pp.5245021-5245021, 2017.

P. Leyssen, J. Balzarini, E. De-clercq, and J. Neyts, The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase, Journal of virology, vol.79, pp.1943-1947, 2005.

D. Todt, In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome, Gut, vol.65, p.1733, 2016.

M. Vignuzzi, J. K. Stone, and R. Andino, Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications, Virus Research, vol.107, pp.173-181, 2005.

M. Lucas-hourani, Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH), Journal of medicinal chemistry, vol.58, pp.5579-5598, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-01170546

M. Lucas-hourani, Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity, PLoS Pathog, vol.9, p.1003678, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-01113535

C. Grandin, Respiratory syncytial virus infection in macaques is not suppressed by intranasal sprays of pyrimidine biosynthesis inhibitors, Antiviral Res, vol.125, pp.58-62, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01273178

A. Khatun, N. Shabir, K. J. Yoon, and W. I. Kim, Effects of ribavirin on the replication and genetic stability of porcine reproductive and respiratory syndrome virus, BMC Vet. Res, vol.11, p.21, 2015.

J. C. Rappe, Antiviral activity of K22 against members of the order Nidovirales, Virus Res, vol.246, pp.28-34, 2018.

S. Vairo, W. Van-den-broeck, H. Favoreel, A. Scagliarini, and H. Nauwynck, Development and use of a polarized equine upper respiratory tract mucosal explant system to study the early phase of pathogenesis of a European strain of equine arteritis virus, Veterinary research, vol.44, p.22, 2013.

W. Knecht and M. Loffler, Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives, Biochem Pharmacol, vol.56, pp.1259-1264, 1998.

D. Chung, The Establishment of an Antiviral State by Pyrimidine Synthesis Inhibitor is Cell Type-Specific, Journal of antimicrobial agents, vol.1, p.101, 2015.

D. Falzarano, Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques, Nat Med, vol.19, pp.1313-1317, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01543320

N. N. Cheung, Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response, The Journal of general virology, vol.98, pp.946-954, 2017.

M. Lucas-hourani, Original Chemical Series of Pyrimidine Biosynthesis Inhibitors That Boost the Antiviral Interferon Response, Antimicrob Agents Chemother, p.61, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01693518

G. Li and E. De-clercq, Therapeutic options for the 2019 novel coronavirus (2019-nCoV), Nat. Rev. Drug Discov, vol.19, pp.149-150, 2020.